Results 141 to 150 of about 1,262,741 (193)

Polycystic ovary syndrome and menopausal transition: Hormonal dynamics, phenotypic evolution, and ethnic considerations. [PDF]

Acta Obstet Gynecol Scand
Lv D.
europepmc   +1 more source

Prevalence of polycystic ovary syndrome among college students in kashmir (J&K) india: a cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Ganaie MA, Hassan MT, Sudershan A, Raina RJ, Shah M, Fidda MU, Pushap AC, Gaffar S, Lee SJ.   +8 more
europepmc   +1 more source

Efficacy of acupuncture therapies for polycystic ovary syndrome: a network meta-analysis. [PDF]

Front Med (Lausanne)
Yang N, Li Y, Jiang H, Wang R, Zhang Q, Tang Q, Liu H, Xie Y, Wang S, Li Z, Dong Z, Zhao J, Wang F.   +12 more
europepmc   +1 more source

The Role of Antioxidants in the Management of Polycystic Ovary Syndrome. [PDF]

Antioxidants (Basel)
Sorić T, Matek Sarić M, Herceg Romanić S, Sarić A, Jonjić A, Čoklo M.   +5 more
europepmc   +1 more source

The gut microbiome in polycystic ovary syndrome: mechanistic pathways and therapeutic potential of microbiota-targeted interventions. [PDF]

Front Endocrinol (Lausanne)
Elhennawy F, Naji B, Butler AE.
europepmc   +1 more source

Insulin Resistance in Polycystic Ovary Syndrome: Mechanistic Insights and Therapeutic Perspectives Independent of Obesity. [PDF]

Gynecol Minim Invasive Ther
Abhinethri B, Harindranathan DN, Kurian SJ.   +2 more
europepmc   +1 more source

The role of body composition, irisin, and FABP4 levels in adolescent girls with polycystic ovary syndrome. [PDF]

BMC Endocr Disord
Kara L, Siraz UG, Muhtaroglu S, Sungur N, Hatipoglu N.   +4 more
europepmc   +1 more source

The Limited Diagnostic Utility of Metabolic and Inflammatory Indices in Adolescent Polycystic Ovary Syndrome: A Case-Control Study. [PDF]

Biomedicines
Ustebay S, Deniz R, Tigli A, Akinci GE, Uzuner MB, Sener N, Degirmenci YE, Ustebay DU, Karakoç O, Yardibi YS, Almak D, Baykus Y.   +11 more
europepmc   +1 more source

Polycystic ovary syndrome

The Lancet Diabetes & Endocrinology, 2022
Polycystic ovary syndrome (PCOS) affects 5-18% of women, and is a reproductive, metabolic, and psychological condition with impacts across the lifespan. The cause is complex, and includes genetic and epigenetic susceptibility, hypothalamic and ovarian dysfunction, excess androgen exposure, insulin resistance, and adiposity-related mechanisms. Diagnosis
Anju E, Joham, Robert J, Norman, Elisabet, Stener-Victorin, Richard S, Legro, Stephen, Franks, Lisa J, Moran, Jacqueline, Boyle, Helena J, Teede   +7 more
core   +6 more sources